WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samuel Bates MartinSVP AND CFO2026-01-024,817$10.38
$50.00kBuy
Ronald PepinSR. VP CBO2025-12-158,333$9.02
$75.14kBuy
Ronald PepinSR. VP CBO2025-12-1511,000$2.78
$30.58kBuy
Freddy A. JimenezSVP GENERAL COUNSEL2025-12-044,166$29.10
$121.21kSell
Richard M. WrightInsider2025-11-1349,298$24.00
$1.18MSell
Richard M. WrightInsider2025-11-1326,672$10.38
$276.86kBuy
Richard M. WrightInsider2025-11-1315,750$22.48
$354.06kBuy
Richard M. WrightInsider2025-11-136,876$9.02
$62.00kBuy
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13430$25.42
$10.93kSell
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13341$23.95
$8.17kSell

1 of 1

CLDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wellington Management Group LLP10.91%8,560,476$329.45MInstitution
Thomas S. Paluck9.72%7,632,346$293.73MInsider
Kynam Capital Management LP7.44%5,840,567$224.77MInstitution
Blackrock Inc6.84%5,369,885$206.66MInstitution
Fmr LLC4.78%3,749,048$144.28MInstitution
Point72 Asset Management LP4.11%3,229,939$124.30MInstitution
Vanguard Capital Management LLC3.77%2,960,895$113.95MInstitution
Medarex Inc3.77%2,960,848$113.95MInsider
State Street Corp3.57%2,804,168$107.92MInstitution
Commodore Capital LP3.44%2,696,616$103.78MInstitution

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX85.13%14.87%Net Buying
IRON62.62%37.38%Net SellingNet Buying
QURE86.02%10.00%Net SellingNet Selling
IDYA92.57%7.43%Net BuyingNet Buying
MBX46.52%53.48%Net BuyingNet Selling
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 92.93% institutional shareholders, 16.23% Celldex Therapeutics insiders, and 0.00% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 9.72% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $290.49M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.